Abstract
Forkhead box O (FOXO) factors are tumor suppressor proteins commonly inactivated in human tumors. Furthermore, genetic variation within the FOXO3a gene is consistently associated with human longevity. FOXO proteins are usually inactivated by posttranslational modifications leading to cytoplasmic mislocalization. Therefore, the pharmacological activation by promoting nuclear localization of FOXOs is considered an attractive therapeutic approach to treat cancer and age-related diseases. We developed a cell-based imaging assay to screen for chemical agents capable of inhibiting the nuclear export and in turn trapping proteins that contain a nuclear export sequence including FOXO factors in the nucleus. The fluorescent signal of untreated assay cells localizes predominantly to the cytoplasm. Upon treatment with the nuclear export inhibitors the fluorescent-tagged reporter proteins appear as speckles in the nucleus. In a personalized medicine context, drugs capable of reactivating FOXO factors might be of enormous clinical value in human tumors in which these proteins are inactivated. Here, we describe the procedures for monitoring nuclear export which is suitable for high-throughput screening of compound collections.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Hung MC, Link W (2011) Protein localization in disease and therapy. J Cell Sci 124(Pt 20):3381–3392. https://doi.org/10.1242/jcs.089110124/20/3381 [pii]
Hill R, Cautain B, de Pedro N, Link W (2014) Targeting nucleocytoplasmic transport in cancer therapy. Oncotarget 5(1):11–28. https://doi.org/10.18632/oncotarget.1457 1457[pii]
Zanella F, Link W, Carnero A (2010) Understanding FOXO, new views on old transcription factors. Curr Cancer Drug Targets 10(2):135–146 doi:EPub-Abstract-CCDT-02 [pii]
Link W, Fernandez-Marcos PJ (2017) FOXO transcription factors at the interface of metabolism and cancer. Int J Cancer 141(12):2379–2391. https://doi.org/10.1002/ijc.30840
Martins R, Lithgow GJ, Link W (2016) Long live FOXO: unraveling the role of FOXO proteins in aging and longevity. Aging Cell 15(2):196–207. https://doi.org/10.1111/acel.12427
Zanella F, Dos Santos NR, Link W (2013) Moving to the core: spatiotemporal analysis of Forkhead box O (FOXO) and nuclear factor-kappaB (NF-kappaB) nuclear translocation. Traffic 14(3):247–258. https://doi.org/10.1111/tra.12034
Kau TR, Way JC, Silver PA (2004) Nuclear transport and cancer: from mechanism to intervention. Nat Rev Cancer 4(2):106–117. https://doi.org/10.1038/nrc1274
Zanella F, Rosado A, Blanco F, Henderson BR, Carnero A, Link W (2007) An HTS approach to screen for antagonists of the nuclear export machinery using high content cell-based assays. Assay Drug Dev Technol 5(3):333–341. https://doi.org/10.1089/adt.2007.058
Zanella F, Rosado A, Garcia B, Carnero A, Link W (2009) Using multiplexed regulation of luciferase activity and GFP translocation to screen for FOXO modulators. BMC Cell Biol 10(14):1471–2121
Kauselmann G, Dopazo A, Link W (2012) Identification of disease-relevant genes for molecularly-targeted drug discovery. Curr Cancer Drug Targets 12(1):1–13 doi:BSP/CCDT/E-Pub/00174 [pii]
Zhang JH, Chung TD, Oldenburg KR (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4(2):67–73. https://doi.org/10.1177/108705719900400206
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46(1–3):3–26 doi:S0169-409X(00)00129-0 [pii]
Acknowledgments
This work was supported by Fundação para a Ciência e a Tecnologia (FCT) Research Center Grant UID/BIM/04773/2013 Centre for Biomedical Research 1334. Work in the laboratory of WL was funded by a research grant from Liga Portuguesa Contra o Cancro – Núcleo Regional do Sul (LPCC/NRS), Terry Fox. B. I. Ferreira is the recipient of a FCT 2014 research grant SFRH/BPD/100434/2014. S. Machado is the recipient of a ProRegem grant PD/BD/114258/2016.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Machado, S., Raposo, C., Ferreira, B.I., Link, W. (2019). Image-based Identification of Chemical Compounds Capable of Trapping FOXO in the Cell Nucleus. In: Link, W. (eds) FOXO Transcription Factors. Methods in Molecular Biology, vol 1890. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-8900-3_14
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8900-3_14
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-8899-0
Online ISBN: 978-1-4939-8900-3
eBook Packages: Springer Protocols